Brief: Cereno Scientific Signs Agreement With Inorbit Therapeutics

Cereno Scientific AB

10/12/2019 14:35

Dec 10 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC BROADENS ITS PIPELINE - SIGNS AGREEMENT
ON
ACQUISITION OF COMPOUND IN PRECLINICAL PHASE
    * CERENO SCIENTIFIC BROADENS ITS PIPELINE - SIGNS AGREEMENT
ON
ACQUISITION OF COMPOUND IN PRECLINICAL PHASE
    * ANNOUNCED TODAY THAT COMPANY HAS SIGNED AN AGREEMENT WITH
INORBIT THERAPEUTICS AB REGARDING ACQUISITION OF A NEW COMPOUND
IN PRECLINICAL PHASE
    * COMPOUND CS036 PROVIDES A FURTHER EXTENSION OF CERENO
SCIENTIFIC'S PORTFOLIO IN CARDIOVASCULAR DISEASES.
    * AGREEMENT WITH INORBIT THERAPEUTICS MEANS THAT CERENO
SCIENTIFIC
WILL TAKE OVER ALL RIGHTS RELATED TO COMPOUND AND RELATED
COMPOUND FAMILY

Source text for Eikon:  ID:nWkrbF7sx6 
Further company coverage:  CRNOSb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))